cp wire

CP Wire Articles

Inovio Closes License and Collaboration Agreement with ApolloBio To Develop and Commercialize DNA Immunotherapy product (VGX-3100) in Greater China

Inovio announced today that it closed an agreement providing ApolloBio Corp. (NEEQ:430187) with the exclusive right to develop, manufacture and commercialize VGX-3100, Inovio’s DNA immunotherapy... read more

Tue, 03/20/18 - 10:11 am
Cotinga Pharmaceuticals Provides Update on COTI-2 PhI Clinical Programs

Cotinga announced that it has submitted an updated clinical package to regulatory authorities to expand its ongoing Phase 1 trial of COTI-2. The protocol amendment will expand the clinical trial... read more

Tue, 03/20/18 - 09:43 am
Healthcare on the Hill - Alternatives to Opioids (ALTO) in the Emergency Department Act (S2516)

S2516: Alternatives to Opioids (ALTO) in the Emergency Department Act

This bill was introduced by Senator Corey Booker (D-NJ) on 3/7/2018 and cosponsored by Senators... read more

Mon, 03/19/18 - 01:20 pm
Healthcare on the Hill - a bill that would classify all opioid mu receptor agonists schedule I (H.R.5298)

This bill was introduced by David P Roe (R-TN) on 3/15/2018. The full text of the bill has yet to be posted. The full title of the bill is:

H.R.5298 - To amend the Controlled... read more

Mon, 03/19/18 - 12:34 pm
Landmark study shows Opko 4Kscore test useful guide in choosing prostate cancer treatment options

OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology

OPKO Health, Inc. (NASDAQ:OPK) today announced that... read more

Fri, 03/16/18 - 11:06 am

Pages